Studies in tumors have mainly focused on their targeted inhibitory effect on the STAT3 signaling pathway, inhibiting STAT3 phosphorylation, DNA‐binding activity, and transcriptional activation to induce apoptosis in pancreatic cancer and breast cancer cells [5, 8]. This evidence concerns the gene STAT3 and breast cancer.